Merit Medical Systems, Inc. (MMSI) P/E Ratio History
Historical price-to-earnings valuation from 1992 to 2026
Loading P/E history...
MMSI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Merit Medical Systems, Inc. (MMSI) trades at a price-to-earnings ratio of 29.3x, with a stock price of $62.33 and trailing twelve-month earnings per share of $2.32.
The current P/E is 48% below its 5-year average of 56.2x. Over the past five years, MMSI's P/E has ranged from a low of 29.8x to a high of 130.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, MMSI trades at a 31% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, MMSI trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MMSI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MMSI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 30.4 | 6.91 | -15% | |
| $2B | 6.9Lowest | 0.67Best | +817%Best | |
| $84B | 29.2 | - | +55% | |
| $56B | 26.3 | 1.59 | -1% | |
| $100B | 21.6 | - | +31% | |
| $113B | 35.0 | 2.36 | +8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MMSI Historical P/E Data (1992–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $68.93 | $2.31 | 29.8x | -38% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $88.14 | $2.12 | 41.6x | -14% |
| FY2025 Q3 | $83.23 | $1.95 | 42.7x | -11% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $93.48 | $1.97 | 47.5x | -1% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $105.71 | $2.04 | 51.8x | +8% |
| FY2024 Q4 | $96.72 | $2.03 | 47.6x | -1% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $98.83 | $2.04 | 48.4x | +1% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $85.95 | $2.00 | 43.0x | -11% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $75.75 | $1.74 | 43.5x | -10% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $75.96 | $1.62 | 46.9x | -3% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $69.02 | $1.73 | 39.9x | -17% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $83.64 | $1.56 | 53.6x | +11% |
Average P/E for displayed period: 48.1x
See MMSI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MMSI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MMSI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMMSI — Frequently Asked Questions
Quick answers to the most common questions about buying MMSI stock.
Is MMSI stock overvalued or undervalued?
MMSI trades at 29.3x P/E, below its 5-year average of 56.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MMSI's valuation compare to peers?
Merit Medical Systems, Inc. P/E of 29.3x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is MMSI's PEG ratio?
MMSI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1992-2026.